What is the recommended dosing frequency for the Anora (beclomethasone) inhaler?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anora (Beclomethasone) Inhaler Dosing Frequency

Inhaled beclomethasone should be administered twice daily for most patients with persistent asthma, with total daily doses ranging from 400-800 μg divided into two administrations. 1

Standard Dosing Regimen

  • Beclomethasone is effective when given twice daily (morning and evening) for patients with stable asthma, which is the recommended frequency for optimal symptom control. 1, 2

  • The typical starting dose is 400-800 μg per day divided into two doses (200-400 μg twice daily), which provides adequate control for most patients with mild to moderate persistent asthma. 1, 3

  • Four times daily dosing at the same total daily dose may be considered if symptoms are not controlled on twice daily administration, though this approach maintains the same total daily dose rather than increasing it. 1

Dose Escalation Strategy

  • If standard doses fail to control symptoms, increase the total daily dose up to 2000 μg beclomethasone equivalent before adding additional medications or changing frequency. 1, 2

  • Higher doses (up to 2000 μg daily) have been shown to provide additional clinical benefit in patients unresponsive to usual therapeutic dosages of 400-800 μg daily. 2

Once Daily Dosing Considerations

  • Once daily dosing is NOT recommended for beclomethasone as the primary maintenance regimen, unlike some combination products (budesonide/formoterol) which have demonstrated efficacy with once-daily evening administration. 4

  • Beclomethasone 400 μg daily is equally effective when administered in 2 or 4 divided doses in patients with stable asthma only, but lower frequency administration is likely less effective when asthma is unstable. 2

Clinical Pearls

  • Spacer devices should be used with metered-dose inhalers to increase lung deposition from 20-30% to significantly higher levels, improving effectiveness. 1

  • Patients should demonstrate 1-3 months of stability before attempting stepwise dose reduction, decreasing by 25-50% at each step. 1

  • Proper inhaler technique must be verified at each visit, as many patients use inhalers incorrectly, reducing therapeutic benefit regardless of dosing frequency. 1

Important Caveats

  • Beclomethasone has a delayed onset of action and should never be used for acute exacerbations; oral corticosteroids (30-40 mg prednisolone daily) are required for acute worsening. 1, 3

  • The most common side effect is oropharyngeal candidiasis, which is dose-related and more common in women; using a spacer device and rinsing the mouth after use reduces this risk. 3, 5

  • Patients transferring from systemic corticosteroids require 9-12 months of careful monitoring until hypothalamic-pituitary-adrenal axis recovery is sufficient to handle stress situations. 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.